Testing the Timing of Pembrolizumab Alone or With Chemotherapy as First Line Treatment and Maintenance in Non-small Cell Lung Cancer

~37 mi. (Auburn, New York, +664 more cities)

Hematology Oncology Associates of Central New York-Auburn

PD-L1 High Expression (TPS >= 1%), +1 more biomarker

Non-Small Cell Lung Carcinoma

carboplatin, +2 more drugs

chemotherapy, +1 more type

Combination Chemotherapy With or Without Atezolizumab in Treating Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair

~37 mi. (Auburn, New York, +656 more cities)

Hematology Oncology Associates of Central New York-Auburn

Deficient DNA Mismatch Repair (dMMR), +8 more biomarkers

Colon Adenocarcinoma, +1 more condition

atezolizumab, +3 more drugs

chemotherapy, +1 more type

CompassHER2-pCR: Decreasing Chemotherapy for Breast Cancer Patients After Pre-surgery Chemo and Targeted Therapy

~37 mi. (Auburn, New York, +533 more cities)

Hematology Oncology Associates of Central New York-Auburn

ERBB2 Amplification, +1 more biomarker

Invasive Breast Carcinoma

ado-trastuzumab emtansine, +6 more drugs

chemotherapy, +2 more types

Testing the Drug Atezolizumab or Placebo With Usual Therapy in First-Line HER2-Positive Metastatic Breast Cancer

~37 mi. (Auburn, New York, +497 more cities)

Hematology Oncology Associates of Central New York-Auburn

HER2 Positive

Breast Adenocarcinoma

atezolizumab, +4 more drugs

chemotherapy, +2 more types

Testing the Addition of an Antibody to Standard Chemoradiation Followed by the Antibody for One Year to Standard Chemoradiation Followed by One Year of the Antibody in Patients With Unresectable Stage III Non-Small Cell Lung Cancer

~37 mi. (Auburn, New York, +469 more cities)

Hematology Oncology Associates of Central New York-Auburn

Non-Small Cell Lung Carcinoma

carboplatin, +6 more drugs

chemotherapy, +2 more types

Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)

~37 mi. (Auburn, New York, +954 more cities)

Hematology Oncology Associates of Central New York-Auburn

Non-Small Cell Lung Carcinoma

crizotinib, +4 more drugs

chemotherapy, +2 more types

Testing Cabozantinib in Patients With Advanced Pancreatic Neuroendocrine and Carcinoid Tumors

~37 mi. (Auburn, New York, +279 more cities)

Hematology Oncology Associates of Central New York-Auburn

Neuroendocrine Tumor

cabozantinib

targeted therapy

Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy

~37 mi. (Auburn, New York, +637 more cities)

Hematology Oncology Associates of Central New York-Auburn

ER Negative, +2 more biomarkers

Invasive Breast Carcinoma

capecitabine, +2 more drugs

chemotherapy

Testing the Effects of MK-3475 (Pembrolizumab) With or Without the Usual Chemotherapy Treatment for Patients 70 Years of Age and Older With Advanced Non-small Cell Lung Cancer

~37 mi. (Auburn, New York, +256 more cities)

Hematology Oncology Associates of Central New York-Auburn

Non-Small Cell Lung Carcinoma

carboplatin, +2 more drugs

chemotherapy, +1 more type

Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck Cancer

~43 mi. (Elmira, New York, +224 more cities)

Arnot Ogden Medical Center/Falck Cancer Center

HPV Negative

Hypopharyngeal Carcinoma, +3 more conditions

atezolizumab, +4 more drugs

chemotherapy, +3 more types

Testing the Addition of the Drug Atezolizumab to the Usual Radiation Treatment for Patients With Early Non-small Cell Lung Cancer

~43 mi. (Elmira, New York, +175 more cities)

Arnot Ogden Medical Center/Falck Cancer Center

Non-Small Cell Lung Carcinoma

atezolizumab, +1 more drug

immunotherapy, +2 more types

Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer

~43 mi. (Elmira, New York, +577 more cities)

Arnot Ogden Medical Center/Falck Cancer Center

Non-Small Cell Lung Carcinoma